About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 138797, 10 pages
http://dx.doi.org/10.1155/2012/138797
Review Article

Human L-Ficolin (Ficolin-2) and Its Clinical Significance

1Scottish National Blood Transfusion Service, National Science Laboratory, Ellen’s Glen Road, Edinburgh EH17 7QT, UK
2MRC Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK

Received 15 September 2011; Accepted 14 November 2011

Academic Editor: Misao Matsushita

Copyright © 2012 David C. Kilpatrick and James D. Chalmers. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Ichijo, L. Ronnstrand, K. Miyagawa, H. Ohashi, C.-H. Heldin, and K. Miyazono, “Purification of transforming growth factor-β1 binding proteins from porcine uterus membranes,” The Journal of Biological Chemistry, vol. 266, no. 33, pp. 22459–22464, 1991.
  2. M. Matsushita, Y. Endo, S. Taira et al., “A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin,” The Journal of Biological Chemistry, vol. 271, no. 5, pp. 2448–2454, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Le, S. M. Tan, S. H. Lee, O. L. Kon, and J. Lu, “Purification and binding properties of a human ficolin-like protein,” Journal of Immunological Methods, vol. 204, no. 1, pp. 43–49, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Harumiya, A. Omori, T. Sugiura, Y. Fukumoto, H. Tachikawa, and D. Fujimoto, “EBP-37, a new elastin-binding protein in human plasma: structural similarity to ficolins, transforming growth factor-β1-binding proteins,” Journal of Biochemistry, vol. 117, no. 5, pp. 1029–1035, 1995. View at Scopus
  5. P. F. Edgar, “Hucolin, a new corticosteroid-binding protein from human plasma with structural similarities to ficolins, transforming growth factor-β1-binding proteins,” FEBS Letters, vol. 375, no. 1-2, pp. 159–161, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. D. C. Kilpatrick, “Mannan-binding lectin: clinical significance and applications,” Biochimica et Biophysica Acta, vol. 1572, no. 2-3, pp. 401–413, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Ohashi and H. P. Erickson, “Two oligomeric forms of plasma ficolin have differential lectin activity,” The Journal of Biological Chemistry, vol. 272, no. 22, pp. 14220–14226, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Brooks, J. Hammermueller, J. P. DeLay, and M. A. Hayes, “Expression and secretion of ficolin β by porcine neutrophils,” Biochimica et Biophysica Acta, vol. 1624, no. 1–3, pp. 36–45, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Fujimori, S. Harumiya, Y. Fukumoto et al., “Molecular cloning and characterization of mouse ficolin-a,” Biochemical and Biophysical Research Communications, vol. 244, no. 3, pp. 796–800, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. T. Ohashi and H. P. Erickson, “Oligomeric structure and tissue distribution of ficolins from mouse, pig and human,” Archives of Biochemistry and Biophysics, vol. 360, no. 2, pp. 223–232, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. Y. Kakinuma, Y. Endo, M. Takahashi et al., “Molecular cloning and characterization of novel ficolins from Xenopus laevis,” Immunogenetics, vol. 55, no. 1, pp. 29–37, 2003. View at Scopus
  12. M. Matsushita, “The ficolin family: an overview,” in Collagen-Related Lectins in Innate Immunity, D. Kilpatrick, Ed., pp. 17–31, Research Signpost, 2007.
  13. P. Garred, C. Honoré, Y. J. Ma et al., “The genetics of ficolins,” Journal of Innate Immunity, vol. 2, no. 1, pp. 3–16, 2009. View at Publisher · View at Google Scholar · View at PubMed
  14. R. Sugimoto, Y. Yae, M. Akaiwa et al., “Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family,” The Journal of Biological Chemistry, vol. 273, no. 33, pp. 20721–20727, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Hummelshoj, L. M. Fog, H. O. Madsen, R. B. Sim, and P. Garred, “Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen),” Molecular Immunology, vol. 45, no. 6, pp. 1623–1632, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. H. Keshi, T. Sakomoto, T. Kawai, et al., “Identificationand characterization of novel human collectin CL-K1,” Microbiology and Immunology, vol. 50, pp. 1001–1013, 2006.
  17. S. Hansen, L. Selman, N. Palaniyar et al., “Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity,” Journal of Immunology, vol. 185, no. 10, pp. 6096–6104, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. Y. G. Ma, M. Y. Cho, M. Zhao et al., “Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement,” The Journal of Biological Chemistry, vol. 279, no. 24, pp. 25307–25312, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. V. Garlatti, N. Belloy, L. Martin et al., “Structural insights into the innate immune recognition specificities of L- and H-ficolins,” The EMBO Journal, vol. 26, no. 2, pp. 623–633, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. Y. Endo, Y. Sato, M. Matsushita, and T. Fujita, “Cloning and characterization of the human lectin P35 gene and its related gene,” Genomics, vol. 36, no. 3, pp. 515–521, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. T. Hummelshoj, L. Munthe-Fog, H. O. Madsen, T. Fujita, M. Matsushita, and P. Garred, “Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2,” Human Molecular Genetics, vol. 14, no. 12, pp. 1651–1658, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. B. L. Herpers, M. M. Immink, B. A. W. De Jong, H. Van Velzen-Blad, B. M. De Jongh, and E. J. Van Hannen, “Coding and non-coding polymorphisms in the lectin pathway activator L-ficolin gene in 188 Dutch blood bank donors,” Molecular Immunology, vol. 43, no. 7, pp. 851–855, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. T. Hummelshøj, L. Munthe-Fog, H. O. Madsen, and P. Garred, “Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns,” Molecular Immunology, vol. 45, no. 9, pp. 2508–2520, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. Cedzynski, L. Nuytinck, A. P. M. Atkinson et al., “Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene,” Clinical and Experimental Immunology, vol. 150, no. 1, pp. 99–104, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. L. Munthe-Fog, T. Hummelshøj, B. E. Hansen et al., “The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels,” Scandinavian Journal of Immunology, vol. 65, no. 4, pp. 383–392, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. D. C. Kilpatrick, L. A. Mclintock, E. K. Allan et al., “No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections,” Clinical and Experimental Immunology, vol. 134, no. 2, pp. 279–284, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. S. Swierzko, A. Szala, M. Cedzynski et al., “Mannan-binding lectin genotypes and genotype-phenotype relationships in a large cohort of Polish neonates,” Human Immunology, vol. 70, no. 1, pp. 68–72, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. S. L. MacDonald and D. C. Kilpatrick, “Collagen-related defence proteins as animal lectins,” in Collagen-Related Lectins in Innate Immunity, D. Kilpatrick, Ed., pp. 1–16, Research Signpost, 2007.
  29. T. Hummelshoj, N. M. Thielens, H. O. Madsen, G. J. Arlaud, R. B. Sim, and P. Garred, “Molecular organization of human Ficolin-2,” Molecular Immunology, vol. 44, no. 4, pp. 401–411, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. V. Garlatti, L. Martin, M. Lacroix et al., “Structural insights into the recognition properties of human ficolins,” Journal of Innate Immunity, vol. 2, no. 1, pp. 17–23, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. M. Lacroix, C. Dumestre-Pérard, G. Schoehn et al., “Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin,” Journal of Immunology, vol. 182, no. 1, pp. 456–465, 2009. View at Scopus
  32. D. C. Kilpatrick, “Isolation of human mannan binding lectin, serum amyloid P component and related factors from Cohn Fraction III,” Transfusion Medicine, vol. 7, no. 4, pp. 289–294, 1997. View at Scopus
  33. A. Krarup, S. Thiel, A. Hansen, T. Fujita, and J. C. Jensenius, “L-ficolin is a pattern recognition molecule specific for acetyl groups,” The Journal of Biological Chemistry, vol. 279, no. 46, pp. 47513–47519, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. A. Krarup, D. A. Mitchell, and R. B. Sim, “Recognition of acetylated oligosaccharides by human L-ficolin,” Immunology Letters, vol. 118, no. 2, pp. 152–156, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. E. Gout, V. Garlatti, D. F. Smith et al., “Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin,” The Journal of Biological Chemistry, vol. 285, no. 9, pp. 6612–6622, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. N. J. Lynch, S. Roscher, T. Hartung et al., “L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of gram-positive bacteria, and activates the lectin pathway of complement,” Journal of Immunology, vol. 172, no. 2, pp. 1198–1202, 2004. View at Scopus
  37. J. Liu, M. A. M. Ali, Y. Shi et al., “Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation,” Cellular and Molecular Immunology, vol. 6, no. 4, pp. 235–244, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. L. Jensen, C. Honoré, T. Hummelshøj, B. E. Hansen, H. O. Madsen, and P. Garred, “Ficolin-2 recognizes DNA and participates in the clearance of dying host cells,” Molecular Immunology, vol. 44, no. 5, pp. 856–865, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. P. M. L. Ng, A. Le Saux, C. M. Lee et al., “C-reactive protein collaborates with plasma lectins to boost immune response against bacteria,” The EMBO Journal, vol. 26, no. 14, pp. 3431–3440, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. Y. J. Ma, A. Doni, T. Hummelshøj et al., “Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition,” The Journal of Biological Chemistry, vol. 284, no. 41, pp. 28263–28275, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. J. Lu and Y. Le, “Ficolins and the fibrinogen-like domain,” Immunobiology, vol. 199, no. 2, pp. 190–199, 1998. View at Scopus
  42. J. Zhang, J. Koh, J. Lu et al., “Local inflammation induces complement crosstalk which amplifies the antimicrobial response,” PLoS Pathogens, vol. 5, no. 1, Article ID e1000282, 2009. View at Publisher · View at Google Scholar · View at PubMed
  43. A. Krarup, U. B. S. Sørensen, M. Matsushita, J. C. Jensenius, and S. Thiel, “Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules Mannan-binding lectin, L-ficolin, and H-ficolin,” Infection and Immunity, vol. 73, no. 2, pp. 1052–1060, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. Y. Aoyagi, E. E. Adderson, C. E. Rubens et al., “L-ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway,” Infection and Immunity, vol. 76, no. 1, pp. 179–188, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. M. V. Carroll, N. Lack, E. Sim, A. Krarup, and R. B. Sim, “Multiple routes of complement activation by Mycobacterium bovis BCG,” Molecular Immunology, vol. 46, no. 16, pp. 3367–3378, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. I. D. S. Cestari, A. Krarup, R. B. Sim, J. M. Inal, and M. I. Ramirez, “Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi,” Molecular Immunology, vol. 47, no. 2-3, pp. 426–437, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. I. Evans-Osses, E. A. Ansa-Addo, J. M. Inal, and M. I. Ramirez, “Involvement of lectin pathway activation in the complement killing of Giardia intestinalis,” Biochemical and Biophysical Research Communications, vol. 395, no. 3, pp. 382–386, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. M. Matsushita, Y. Endo, and T. Fujita, “Cutting edge: complement-activating complex of ficolin and mannose- binding lectin-associated serine protease,” Journal of Immunology, vol. 164, no. 5, pp. 2281–2284, 2000. View at Scopus
  49. J. S. Presanis, K. Hajela, G. Ambrus, P. Gál, and R. B. Sim, “Differential substrate and inhibitor profiles for human MASP-1 and MASP-2,” Molecular Immunology, vol. 40, no. 13, pp. 921–929, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Krarup, R. Wallis, J. S. Presanis, P. Gál, and R. B. Sim, “Simultaneous activation of complement and coagulation by MBL-associated serine protease 2,” PLoS One, vol. 2, no. 7, article e623, 2007. View at Publisher · View at Google Scholar · View at PubMed
  51. A. Krarup, K. C. Gulla, P. Gál, K. Hajela, and R. B. Sim, “The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen,” Biochimica et Biophysica Acta, vol. 1784, no. 9, pp. 1294–1300, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. K. C. Gulla, K. Gupta, A. Krarup et al., “Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot,” Immunology, vol. 129, no. 4, pp. 482–495, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. K. Takahashi, W. C. Chang, M. Takahashi et al., “Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation,” Immunobiology, vol. 216, no. 1-2, pp. 96–102, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. C. B. Chen and R. Wallis, “Two mechanisms for mannose-binding protein modulation of the activity of its associated serine proteases,” The Journal of Biological Chemistry, vol. 279, no. 25, pp. 26058–26065, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. A. Kocsis, K. A. Kekési, R. Szász et al., “Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and-2: significant contribution of MASP-1 to lectin pathway activation,” Journal of Immunology, vol. 185, no. 7, pp. 4169–4178, 2010. View at Publisher · View at Google Scholar · View at PubMed
  56. M. O. Skjoedt, Y. Palarasah, L. Munthe-Fog et al., “MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation,” Immunobiology, vol. 215, no. 11, pp. 921–931, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. M. Kuraya, Z. Ming, X. Liu, M. Matsushita, and T. Fujita, “Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation,” Immunobiology, vol. 209, no. 9, pp. 689–697, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. D. C. Kilpatrick, “Clinical significance of mannan binding lectin and L-ficolin,” in Collagen-Related Lectins in Innate Immunity, D. C. Kilpatrick, Ed., pp. 57–84, Research Signpost, 2007.
  59. D. C. Kilpatrick, T. Fujita, and M. Matsushita, “P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients,” Immunology Letters, vol. 67, no. 2, pp. 109–112, 1999. View at Publisher · View at Google Scholar · View at Scopus
  60. A. S. Swierzko, A. P. M. Atkinson, M. Cedzynski et al., “Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates,” Molecular Immunology, vol. 46, no. 4, pp. 551–558, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  61. S. Sallenbach, S. Thiel, C. Aebi et al., “Serum concentrations of lectin-pathway components, children and in healthy neonates adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2),” Pediatric Allergy and Immunology, vol. 22, no. 4, pp. 424–430, 2011. View at Publisher · View at Google Scholar · View at PubMed
  62. M. Cedzynski, A. P. M. Atkinson, A. S. Swierzko et al., “L-ficolin (ficolin-2) insufficiency is associated with combined allergic and infectious respiratory disease in children,” Molecular Immunology, vol. 47, no. 2-3, pp. 415–419, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. C. C. Wang, K. W. Yim, T. C. W. Poon et al., “Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia,” Clinical Chemistry, vol. 53, no. 1, pp. 42–52, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. L. J. Schlapbach, M. Mattmann, S. Thiel et al., “Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis,” Clinical Infectious Diseases, vol. 51, no. 2, pp. 153–162, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. S. C.A. Meijvis, B. L. Herpers, H. Endeman et al., “Mannose-binding lectin (MBL2) and ficolin-2 (FCN2) polymorphisms in patients on peritoneal dialysis with staphylococcal peritonitis,” Nephrology Dialysis Transplantation, vol. 26, no. 3, pp. 1042–1045, 2011. View at Publisher · View at Google Scholar · View at PubMed
  66. N. J. Klein and D. C. Kilpatrick, “Is there a role for mannan/mannose-binding lectin (MBL) in defence against infection following chemotherapy for cancer?” Clinical and Experimental Immunology, vol. 138, no. 2, pp. 202–204, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. D. C. Kilpatrick, “Mannan-binding lectin and stem cell transplantation,” in Hematopoietic Stem Cell Transplantation Research Advances, K. B. Neuman, Ed., pp. 1–6, Nova Science, 2008.
  68. B. J. F. de Rooij, B. van Hoek, W. R. Ten Hove et al., “Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation,” Hepatology, vol. 52, no. 3, pp. 1100–1110, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. B.-J. F. de Rooij, M. T. van der Beek, B. van Hoek, et al., “Combined donor-recipient mannose-binding lectin and ficolin-2 gene polymorphisms predispose to human cytomegalovirus infection after orthotopic liver transplantation,” Journal of Hepatology, vol. 54, article S236, 2011.
  70. A. P. M. Atkinson, M. Cedzynski, J. Szemraj et al., “L-ficolin in children with recurrent respiratory infections,” Clinical and Experimental Immunology, vol. 138, no. 3, pp. 517–520, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. J. M. Ruskamp, M. O. Hoekstra, D. S. Postma et al., “Exploring the role of polymorphisms in ficolin genes in respiratory tract infections in children,” Clinical and Experimental Immunology, vol. 155, no. 3, pp. 433–440, 2009. View at Publisher · View at Google Scholar · View at PubMed
  72. S. J. Chapman, F. O. Vannberg, C. C. Khor et al., “Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease,” Molecular Immunology, vol. 44, no. 12, pp. 3267–3270, 2007. View at Publisher · View at Google Scholar · View at PubMed
  73. D. C. Kilpatrick, J. D. Chalmers, S. L. MacDonald et al., “Stable bronchiectasis is associated with low serum L-ficolin concentrations,” Clinical Respiratory Journal, vol. 3, no. 1, pp. 29–33, 2009. View at Publisher · View at Google Scholar · View at PubMed
  74. J. D. Chalmers, D. C. Kilpatrick, B. McHugh, et al., “Single nucleotide polymorphisms in the ficolin-2 gene predispose to Pseudomonas aeruginosa infection and disease severity in non-cystic fibrosis bronchiectasis,” Thorax, vol. 66, supplement 4, pp. A1–A2, 2011.
  75. I. de Messias-Reason, P. G. Kremsner, and J. F. J. Kun, “Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy,” Journal of Infectious Diseases, vol. 199, no. 6, pp. 801–804, 2009. View at Publisher · View at Google Scholar
  76. I. Faik, S. I. Oyedeji, Z. Idris et al., “Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria,” Human Immunology, vol. 72, no. 1, pp. 74–79, 2011. View at Publisher · View at Google Scholar · View at PubMed
  77. A. Assaf, I. Faik, T. Aebischer, et al., “Genetic evidence of functional Ficolin-2 haplotype as susceptibility factor in cutaneous leishmaniasis,” PloS One. In press.
  78. F. E. van de Geijn, A. Roos, Y. A. de Man et al., “Mannose-binding lectin levels during pregnancy: a longitudinal study,” Human Reproduction, vol. 22, no. 2, pp. 362–371, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. I. J. Messias-Reason, M. D. Schafranski, P. G. Kremsner, and J. F. J. Kun, “Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease,” Clinical and Experimental Immunology, vol. 157, no. 3, pp. 395–399, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  80. X. Chen, Y. Katoh, K. Nakamura et al., “Single nucleotide polymorphisms of Ficolin 2 gene in Behçet's disease,” Journal of Dermatological Science, vol. 43, no. 3, pp. 201–205, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  81. C. B. Svendsen, T. Hummelshøj, L. Munthe-Fog et al., “Ficolins and Mannose-Binding Lectin in Danish patients with sarcoidosis,” Respiratory Medicine, vol. 102, no. 9, pp. 1237–1242, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. A. Roos, M. P. Rastaldi, N. Calvaresi et al., “Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease,” Journal of the American Society of Nephrology, vol. 17, no. 6, pp. 1724–1734, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. N. Imai, S. Nishi, B. Alchi et al., “Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition,” Nephrology Dialysis Transplantation, vol. 21, no. 9, pp. 2589–2595, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  84. N. D. Keirstead, C. Lee, D. Yoo, A. S. Brooks, and M. A. Hayes, “Porcine plasma ficolin binds and reduces infectivity of porcine reproductive and respiratory syndrome virus (PRRSV) in vitro,” Antiviral Research, vol. 77, no. 1, pp. 28–38, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  85. N. D. Keirstead, M. A. Hayes, G. E. Vandervoort, A. S. Brooks, E. J. Squires, and B. N. Lillie, “Single nucleotide polymorphisms in collagenous lectins and other innate immune genes in pigs with common infectious diseases,” Veterinary Immunology and Immunopathology, vol. 142, no. 1-2, pp. 1–13, 2011. View at Publisher · View at Google Scholar · View at PubMed
  86. I. C. Michelow, M. Dong, B. A. Mungall et al., “A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus,” The Journal of Biological Chemistry, vol. 285, no. 32, pp. 24729–24739, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. Y. Endo, M. Matsushita, and T. Fujita, “The role of ficolins in the lectin pathway of innate immunity,” International Journal of Biochemistry and Cell Biology, vol. 43, no. 5, pp. 705–712, 2011. View at Publisher · View at Google Scholar · View at PubMed
  88. Y. Ma, F. Luo, T. Xiang, et al., “Effects of L-ficolin on host resistance, gamma interferon production and phagocytosis against Salmonella infection,” Molecular Immunology, vol. 44, p. 211, 2011. View at Publisher · View at Google Scholar